Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Optimer Shares Rise on FDA Panel Vote

By Pharmaceutical Processing | April 6, 2011

Shares of Optimer Pharmaceuticals
Inc. rose in pre-market trading today after a government panel recommended
approval of Optimer’s antibiotic Dificid.

On Tuesday, an FDA panel
recommended approval for Dificid, which is intended to treat Clostridium
difficile, a bacterium that can cause diarrhea and dangerous inflammation of
the colon.

Shares rose 25 cents, or 1.8
percent, to $14.05 in pre-market trading. Optimer shares have traded between
$7.68 and $16.30 in the last year.

Jefferies & Co. analyst Eun
Yang said it’s not a guarantee the FDA will approve the drug on May 30. The
panel found Dificid was safe and effective, and panelists voted that it was
more effective than the drug Vancocin in preventing recurrent infections. But
she said the FDA and Optimer may need to hold discussions about the drug’s
label and how it will reflect information about recurrent infections.

Yang said she is conservatively
assuming Dificid will reach the market in the fourth quarter. She kept a
“Buy” rating on Optimer shares, and said she expects worldwide sales
of Dificid to reach $240 million in 2015. She said Optimer should become
profitable in 2014.

 

Related Articles Read More >

This is a screenshot from a Varda Space Industries promotional video showing a space capsule with the company's logo docking onto a satellite.
Varda raises $187M Series C for drug manufacturing in space
This is the logo of Hikma.
Hikma to spend another $1B on US manufacturing, R&D
Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE